All
RSSArticles
-
A New Treatment for Refractory Hyperlipidemia
In patients with familial hypercholesterolemia who are not at target LDL cholesterol levels on maximum-tolerated doses of statins and PCSK9 inhibitors, evinacumab, which inhibits angiopoietin-like 3, reduces LDL by more than 50% at the highest doses with few side effects requiring drug discontinuation vs. placebo.
-
Expanding Uses for Direct Oral Anticoagulants: Bioprosthetic Heart Valves?
A randomized, controlled trial of rivaroxaban vs. warfarin in patients with atrial fibrillation and a bioprosthetic valve revealed rivaroxaban is noninferior to warfarin for the prevention of major cardiovascular events and the avoidance of major bleeding events over 12 months.
-
Time is of the Essence with Colchicine Treatment of Myocardial Infarction
An analysis of the COLCOT study of colchicine administration after myocardial infarction (MI) showed the benefit of this therapy for preventing subsequent cardiovascular events was greatest when therapy was initiated within three days after MI onset.
-
Left Ventricular Size, Function Predictors of Outcomes in Chronic Aortic Regurgitation
In a large cohort of asymptomatic patients with hemodynamically significant chronic aortic regurgitation, volumetric left ventricular size and function measurements were equally discriminant in identifying patients at higher risk for mortality vs. traditional linear measurements.
-
What Causes MINOCA?
A systematic imaging protocol of coronary angiography, optical coherence tomography, and cardiac MRI in women clinically diagnosed with myocardial infarction with non-obstructive coronary artery disease revealed a cause in 84%, with three-quarters exhibiting an ischemic etiology.
-
Study: The Affordable Care Act Improved Contraceptive Use
Data comparing changes in birth rates before and after the Affordable Care Act was passed suggest that reducing out-of-pocket costs is associated with increased contraceptive use.
-
New Research Reveals State Reproductive Rights Affect Risks for Newborns
The authors of a recent study found that Black women in the United States have a lower risk of giving birth to low birth weight babies if they live in states with less restrictive reproductive rights, when compared with women who live in states with more restrictive policies.
-
Researchers Suggest It Is Time to End the Default Pelvic Exam
Women who seek most forms of contraception do not need a routine pelvic examination before they are prescribed a contraceptive. Still, these exams are routine for many OB/GYN offices and reproductive health clinics, and this creates a barrier for some women — particularly those who have experienced sexual assault and intimate partner violence, according to new research.
-
Family Planning Providers Can Reduce Negative Perceptions of IUDs
Despite the safety and efficacy of the intrauterine device (IUD) and the reduction of cost barriers since the Affordable Care Act, only about 12% of American women use that method of contraception. Research shows that the women most likely to use an IUD or implant are ages 25 to 34 years, were born outside of the United States, live in a Western state, and report their religious affiliation as “other."
-
Clinicians Can Help Reduce Stigma Around Substance Use Disorder
Stigma is a major barrier to women with substance use disorder receiving reproductive healthcare and contraceptives. Clinicians should ask women, including those with substance use disorder, about their goals, values, and what they find most important in contraception.